| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) | ||||||
| (Address of principal executive offices) | ||
| Title of class | Trading symbol(s) | Name of exchange on which registered | ||||||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit No. | Exhibit Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document). | |||||||
| ADIENT PLC | ||||||||
| Date: August 5, 2022 | By: | /s/ Heather M. Tiltmann | ||||||
| Name: | Heather M. Tiltmann | |||||||
| Title: | Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary | |||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions, except per share data) | 2022 | 2021 | ||||||||||||
| Net sales | $ | 3,485 | $ | 3,242 | ||||||||||
| Cost of sales | 3,312 | 3,092 | ||||||||||||
| Gross profit | 173 | 150 | ||||||||||||
| Selling, general and administrative expenses | 142 | 136 | ||||||||||||
| Restructuring and impairment costs | 12 | 8 | ||||||||||||
| Equity income (loss) | 16 | 38 | ||||||||||||
| Earnings (loss) before interest and income taxes | 35 | 44 | ||||||||||||
| Net financing charges | 39 | 87 | ||||||||||||
| Other pension expense (income) | (4) | (4) | ||||||||||||
| Income (loss) before income taxes | — | (39) | ||||||||||||
| Income tax provision (benefit) | 20 | 10 | ||||||||||||
| Net income (loss) | (20) | (49) | ||||||||||||
| Income attributable to noncontrolling interests | 10 | 22 | ||||||||||||
| Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
| Diluted earnings (loss) per share | $ | (0.32) | $ | (0.75) | ||||||||||
| Shares outstanding at period end | 94.8 | 94.2 | ||||||||||||
| Diluted weighted average shares | 94.8 | 94.2 | ||||||||||||
| June 30, | September 30, | |||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 892 | $ | 1,521 | ||||||||||
Accounts receivable - net | 1,761 | 1,426 | ||||||||||||
| Inventories | 953 | 976 | ||||||||||||
| Assets held for sale | — | 49 | ||||||||||||
| Other current assets | 456 | 1,114 | ||||||||||||
| Current assets | 4,062 | 5,086 | ||||||||||||
| Property, plant and equipment - net | 1,443 | 1,607 | ||||||||||||
| Goodwill | 2,122 | 2,212 | ||||||||||||
| Other intangible assets - net | 504 | 555 | ||||||||||||
| Investments in partially-owned affiliates | 348 | 335 | ||||||||||||
| Assets held for sale | 7 | 25 | ||||||||||||
| Other noncurrent assets | 829 | 958 | ||||||||||||
| Total assets | $ | 9,315 | $ | 10,778 | ||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||
| Short-term debt | $ | 20 | $ | 184 | ||||||||||
| Accounts payable and accrued expenses | 2,697 | 2,519 | ||||||||||||
| Liabilities held for sale | — | 16 | ||||||||||||
| Other current liabilities | 670 | 792 | ||||||||||||
| Current liabilities | 3,387 | 3,511 | ||||||||||||
| Long-term debt | 2,707 | 3,512 | ||||||||||||
| Other noncurrent liabilities | 723 | 797 | ||||||||||||
| Redeemable noncontrolling interests | 45 | 240 | ||||||||||||
| Shareholders' equity attributable to Adient | 2,123 | 2,376 | ||||||||||||
| Noncontrolling interests | 330 | 342 | ||||||||||||
| Total liabilities and shareholders' equity | $ | 9,315 | $ | 10,778 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Operating Activities | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
| Income attributable to noncontrolling interests | 10 | 22 | ||||||||||||
| Net income (loss) | (20) | (49) | ||||||||||||
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: | ||||||||||||||
| Depreciation | 72 | 71 | ||||||||||||
| Amortization of intangibles | 14 | 10 | ||||||||||||
| Pension and postretirement benefit expense (benefit) | (3) | (1) | ||||||||||||
| Pension and postretirement contributions, net | (7) | (6) | ||||||||||||
| Equity in earnings of partially-owned affiliates, net of dividends received | 10 | 245 | ||||||||||||
| Deferred income taxes | 13 | (2) | ||||||||||||
| Non-cash restructuring and impairment charges | 1 | 1 | ||||||||||||
| Equity-based compensation | 7 | 10 | ||||||||||||
| Other | — | 8 | ||||||||||||
| Changes in assets and liabilities: | ||||||||||||||
| Receivables | (83) | 315 | ||||||||||||
| Inventories | 8 | (87) | ||||||||||||
| Other assets | 7 | 14 | ||||||||||||
| Restructuring reserves | (11) | (23) | ||||||||||||
| Accounts payable and accrued liabilities | 37 | (277) | ||||||||||||
| Accrued income taxes | (22) | (7) | ||||||||||||
| Cash provided (used) by operating activities | 23 | 222 | ||||||||||||
| Investing Activities | ||||||||||||||
| Capital expenditures | (53) | (60) | ||||||||||||
| Sale of property, plant and equipment | 6 | 11 | ||||||||||||
| Business acquisitions | (13) | (271) | ||||||||||||
| Proceeds from business divestitures | — | 53 | ||||||||||||
| Settlement of an affiliate loan | — | 15 | ||||||||||||
| Cash provided (used) by investing activities | (60) | (252) | ||||||||||||
| Financing Activities | ||||||||||||||
| Increase (decrease) in short-term debt | — | 30 | ||||||||||||
| Increase (decrease) in long-term debt | — | 214 | ||||||||||||
| Repayment of long-term debt | (144) | (185) | ||||||||||||
| Debt financing costs | — | (7) | ||||||||||||
| Dividends paid to noncontrolling interests | (3) | (7) | ||||||||||||
| Other | — | (1) | ||||||||||||
| Cash provided (used) by financing activities | (147) | 44 | ||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | (42) | — | ||||||||||||
| Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale | (226) | 14 | ||||||||||||
| Less: Change in cash classified within current assets held for sale | — | 2 | ||||||||||||
| Increase (decrease) in cash and cash equivalents | $ | (226) | $ | 16 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Net Sales | ||||||||||||||
| Americas | $ | 1,673 | $ | 1,440 | ||||||||||
| EMEA | 1,215 | 1,328 | ||||||||||||
| Asia | 627 | 516 | ||||||||||||
| Eliminations | (30) | (42) | ||||||||||||
| Total net sales | $ | 3,485 | $ | 3,242 | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjusted EBITDA | ||||||||||||||
| Americas | $ | 70 | $ | 23 | ||||||||||
| EMEA | 31 | 22 | ||||||||||||
| Asia | 64 | 92 | ||||||||||||
Corporate-related costs (1) | (22) | (19) | ||||||||||||
Restructuring and impairment costs (2) | (12) | (8) | ||||||||||||
Purchase accounting amortization (3) | (14) | (11) | ||||||||||||
Restructuring related charges (4) | (1) | — | ||||||||||||
| Stock based compensation | (7) | (10) | ||||||||||||
| Depreciation | (72) | (71) | ||||||||||||
Other items (5) | (2) | 26 | ||||||||||||
| Earnings (loss) before interest and income taxes | 35 | 44 | ||||||||||||
| Net financing charges | (39) | (87) | ||||||||||||
| Other pension income (expense) | 4 | 4 | ||||||||||||
| Income (loss) before income taxes | $ | — | $ | (39) | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions, except per share data) | 2022 | 2021 | ||||||||||||
| Income available to shareholders | ||||||||||||||
| Net income (loss) attributable to Adient | $ | (30) | $ | (71) | ||||||||||
| Weighted average shares outstanding | ||||||||||||||
| Basic weighted average shares outstanding | 94.8 | 94.2 | ||||||||||||
| Effect of dilutive securities: | ||||||||||||||
| Stock options, unvested restricted stock and unvested performance share awards | — | — | ||||||||||||
| Diluted weighted average shares outstanding | 94.8 | 94.2 | ||||||||||||
| • | Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales. | ||||
| • | Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented. | ||||
| • | Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits. | ||||
| • | Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes. | ||||
| • | Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares. | ||||
| • | Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income. | ||||
| • | Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense. | ||||
| • | Free cash flow is defined as cash provided by operating activities less capital expenditures. | ||||
| • | Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents. | ||||
| • | "Americas footprint actions" and "EMEA footprint actions" refer to miscellaneous closures / roll off of business. | ||||
| • | "EMEA deconsolidation" refers to sale of a metals business in Turkey effective October 1, 2021 to a nonconsolidated JV in which Adient retains a noncontrolling interest. | ||||
| • | "China strategic transaction" refers to the disposition of the YFAS JV and consolidation of CQADNT and LFADNT, all of which were effective on September 30, 2021. | ||||
| • | "China footprint actions" refers to divestitures of smaller, non-core businesses (i.e., remaining fabrics business and Futuris entity). | ||||
| Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||||||||||||||||
| (in millions, except per share data) | GAAP Results | Adj. | Adjusted Results | GAAP Results | Adj. | Adjusted Results | ||||||||||||||||||||||||||||||||
| Net sales | $ | 3,485 | $ | — | $ | 3,485 | $ | 3,242 | $ | — | $ | 3,242 | ||||||||||||||||||||||||||
Cost of sales (6) | 3,312 | (2) | 3,310 | 3,092 | 28 | 3,120 | ||||||||||||||||||||||||||||||||
| Gross profit | 173 | 2 | 175 | 150 | (28) | 122 | ||||||||||||||||||||||||||||||||
Selling, general and administrative expenses (7) | 142 | (15) | 127 | 136 | (12) | 124 | ||||||||||||||||||||||||||||||||
Restructuring and impairment costs (2) | 12 | (12) | — | 8 | (8) | — | ||||||||||||||||||||||||||||||||
Equity income (loss) (8) | 16 | — | 16 | 38 | 1 | 39 | ||||||||||||||||||||||||||||||||
| Earnings (loss) before interest and income taxes (EBIT) | 35 | 29 | 64 | 44 | (7) | 37 | ||||||||||||||||||||||||||||||||
| Memo accounts: | ||||||||||||||||||||||||||||||||||||||
| Depreciation | 72 | 71 | ||||||||||||||||||||||||||||||||||||
| Equity based compensation | 7 | 10 | ||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 143 | $ | 118 | ||||||||||||||||||||||||||||||||||
Net financing charges (9) | 39 | (2) | 37 | 87 | (38) | 49 | ||||||||||||||||||||||||||||||||
Other pension expense (income) (12) | (4) | 3 | (1) | (4) | 1 | (3) | ||||||||||||||||||||||||||||||||
| Income (loss) before income taxes | — | 28 | 28 | (39) | 30 | (9) | ||||||||||||||||||||||||||||||||
Income tax provision (benefit) (10) | 20 | (11) | 9 | 10 | 7 | 17 | ||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Adient | (30) | 38 | 8 | (71) | 21 | (50) | ||||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share | (0.32) | 0.40 | 0.08 | (0.75) | 0.22 | (0.53) | ||||||||||||||||||||||||||||||||
| Diluted weighted average shares | 94.8 | 0.9 | 95.7 | 94.2 | — | 94.2 | ||||||||||||||||||||||||||||||||
| Three months ended June 30, 2022 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,673 | $ | 1,215 | $ | 627 | $ | (30) | $ | 3,485 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 70 | $ | 31 | $ | 64 | $ | (22) | $ | 143 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 4.2 | % | 2.6 | % | 10.2 | % | N/A | 4.1 | % | |||||||||||||||||||||||
| Three months ended June 30, 2021 | ||||||||||||||||||||||||||||||||
| Americas | EMEA | Asia | Corporate/Eliminations | Consolidated | ||||||||||||||||||||||||||||
| Net sales | $ | 1,440 | $ | 1,328 | $ | 516 | $ | (42) | $ | 3,242 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 23 | $ | 22 | $ | 92 | $ | (19) | $ | 118 | ||||||||||||||||||||||
| Adjusted EBITDA margin | 1.6 | % | 1.7 | % | 17.8 | % | N/A | 3.6 | % | |||||||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Adjusted EBITDA | $ | 143 | $ | 118 | ||||||||||
| Adjusted Equity Income | 16 | 39 | ||||||||||||
| Adjusted EBITDA Excluding Adjusted Equity Income | $ | 127 | $ | 79 | ||||||||||
| % of Sales | 3.6 | % | 2.4 | % | ||||||||||
| Three months ended June 30, | ||||||||||||||||||||||||||||||||||||||
| 2022 | 2021 | |||||||||||||||||||||||||||||||||||||
| (in millions, except effective tax rate) | Income (loss) before income taxes | Tax impact | Effective tax rate | Income (loss) before income taxes | Tax impact | Effective tax rate | ||||||||||||||||||||||||||||||||
| As reported | $ | — | $ | 20 | nm | $ | (39) | $ | 10 | (25.6)% | ||||||||||||||||||||||||||||
Adjustments (10) | 28 | (11) | (39.3)% | 30 | 7 | 23.3% | ||||||||||||||||||||||||||||||||
| As adjusted | $ | 28 | $ | 9 | 32.1% | $ | (9) | $ | 17 | nm | ||||||||||||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Net income (loss) attributable to Adient | (30) | (71) | ||||||||||||
Restructuring and impairment costs | 12 | 8 | ||||||||||||
Purchase accounting amortization | 14 | 11 | ||||||||||||
Restructuring related charges | 1 | — | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) | (3) | (1) | ||||||||||||
Write off of deferred financing costs upon repurchase of debt (9) | — | 10 | ||||||||||||
Derivative loss on Yanfeng transaction (9) | — | 24 | ||||||||||||
Foreign exchange loss on intercompany loan in Russia (9) | 2 | — | ||||||||||||
Premium paid on repurchase of debt (9) | — | 4 | ||||||||||||
Other items (5) | 2 | (26) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (1) | (2) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | 11 | (7) | ||||||||||||
| Adjusted net income (loss) attributable to Adient | $ | 8 | $ | (50) | ||||||||||
| Three Months Ended June 30, | ||||||||||||||
| 2022 | 2021 | |||||||||||||
| Diluted earnings (loss) per share as reported | $ | (0.32) | $ | (0.75) | ||||||||||
| Restructuring and impairment costs | 0.13 | 0.08 | ||||||||||||
| Purchase accounting amortization | 0.15 | 0.12 | ||||||||||||
| Restructuring related charges | 0.01 | — | ||||||||||||
Pension mark-to-market and curtailment/settlement (gain)/loss (12) | (0.03) | (0.01) | ||||||||||||
Write off of deferred financing costs upon repurchase of debt (9) | — | 0.11 | ||||||||||||
Derivative loss on Yanfeng transaction (9) | — | 0.25 | ||||||||||||
Foreign exchange loss on intercompany loan in Russia (9) | 0.02 | — | ||||||||||||
Premium paid on repurchase of debt (9) | — | 0.04 | ||||||||||||
Other items (5) | 0.02 | (0.28) | ||||||||||||
Impact of adjustments on noncontrolling interests (11) | (0.01) | (0.02) | ||||||||||||
Tax impact of above adjustments and other tax items (10) | 0.11 | (0.07) | ||||||||||||
| Adjusted diluted earnings (loss) per share | $ | 0.08 | $ | (0.53) | ||||||||||
| June 30, | September 30, | |||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Cash and cash equivalents | $ | 892 | $ | 1,521 | ||||||||||
| Total short-term and long-term debt | 2,727 | 3,696 | ||||||||||||
| Net debt | $ | 1,835 | $ | 2,175 | ||||||||||
| Three Months Ended June 30, | Nine Months Ended June 30, | |||||||||||||||||||||||||
| (in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||
| Cash provided (used) by operating activities | $ | 23 | $ | 222 | $ | 38 | $ | 362 | ||||||||||||||||||
| Capital expenditures | (53) | (60) | (170) | (186) | ||||||||||||||||||||||
| Free cash flow | $ | (30) | $ | 162 | $ | (132) | $ | 176 | ||||||||||||||||||
| FY2022 | FY2021 | |||||||||||||||||||||||||
| (in millions) | Q3 | YTD | Q3 | YTD | ||||||||||||||||||||||
| Adjusted EBITDA excluding adjusted equity income | $ | 127 | $ | 381 | $ | 79 | $ | 613 | ||||||||||||||||||
| (+) Dividend | 26 | 27 | 283 | 292 | ||||||||||||||||||||||
| (-) Restructuring (cash) | (11) | (49) | (27) | (127) | ||||||||||||||||||||||
| (+/-) Net customer tooling | (15) | (36) | 10 | 10 | ||||||||||||||||||||||
| (+/-) Trade working capital (Net AR/AP + Inventory) | (57) | (6) | (60) | 37 | ||||||||||||||||||||||
| (+/-) Accrued compensation | 2 | (45) | 27 | 35 | ||||||||||||||||||||||
| (-) Interest paid | (23) | (134) | (48) | (184) | ||||||||||||||||||||||
| (+/-) Tax refund/taxes paid | (25) | (63) | (20) | (52) | ||||||||||||||||||||||
| (+/-) Non-income related taxes (VAT) | (20) | 33 | 5 | (73) | ||||||||||||||||||||||
| (+/-) Commercial settlements | (22) | (66) | (8) | (87) | ||||||||||||||||||||||
| (+/-) Capitalized engineering | 31 | 33 | (2) | 11 | ||||||||||||||||||||||
| (+/-) Prepaids | 15 | (8) | (1) | (31) | ||||||||||||||||||||||
| (+/-) Other | (5) | (29) | (16) | (82) | ||||||||||||||||||||||
| Operating cash flow | 23 | 38 | 222 | 362 | ||||||||||||||||||||||
| Capital expenditures | (53) | (170) | (60) | (186) | ||||||||||||||||||||||
| Free cash flow | $ | (30) | $ | (132) | $ | 162 | $ | 176 | ||||||||||||||||||
| Net sales | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
| Americas - as reported: | 1,737 | 1,644 | 1,440 | 1,343 | 6,164 | |||||||||||||||||||||||||||
| Americas footprint actions | (20) | — | — | (1) | (21) | |||||||||||||||||||||||||||
| Americas - pro forma | 1,717 | 1,644 | 1,440 | 1,342 | 6,143 | |||||||||||||||||||||||||||
| EMEA - as reported: | 1,604 | 1,636 | 1,328 | 996 | 5,564 | |||||||||||||||||||||||||||
| EMEA JV deconsolidation | (25) | (28) | (11) | (35) | (99) | |||||||||||||||||||||||||||
| EMEA footprint actions | (18) | (7) | (6) | 1 | (30) | |||||||||||||||||||||||||||
| EMEA - pro forma | 1,561 | 1,601 | 1,311 | 962 | 5,435 | |||||||||||||||||||||||||||
| Asia - as reported: | 554 | 588 | 516 | 465 | 2,123 | |||||||||||||||||||||||||||
| China strategic transactions | 234 | 199 | 231 | 227 | 891 | |||||||||||||||||||||||||||
| China footprint actions | (44) | (33) | (31) | (13) | (121) | |||||||||||||||||||||||||||
| Asia - pro forma | 744 | 754 | 716 | 679 | 2,893 | |||||||||||||||||||||||||||
| Elimination/corporate: | (47) | (49) | (42) | (33) | (171) | |||||||||||||||||||||||||||
| Total Adient - as reported | 3,848 | 3,819 | 3,242 | 2,771 | 13,680 | |||||||||||||||||||||||||||
| Total Adient - pro forma | 3,975 | 3,950 | 3,425 | 2,950 | 14,300 | |||||||||||||||||||||||||||
| Adjusted EBITDA | Q1 | Q2 | Q3 | Q4 | FY2021 | |||||||||||||||||||||||||||
| Americas - as reported: | 132 | 64 | 23 | 13 | 232 | |||||||||||||||||||||||||||
| Americas footprint actions | (5) | 1 | — | (1) | (5) | |||||||||||||||||||||||||||
| Americas - pro forma | 127 | 65 | 23 | 12 | 227 | |||||||||||||||||||||||||||
| EMEA - as reported: | 114 | 141 | 22 | — | 277 | |||||||||||||||||||||||||||
| EMEA JV deconsolidation | (4) | (5) | — | (8) | (17) | |||||||||||||||||||||||||||
| EMEA footprint actions | (6) | (2) | (1) | (1) | (10) | |||||||||||||||||||||||||||
| EMEA - pro forma | 104 | 134 | 21 | (9) | 250 | |||||||||||||||||||||||||||
| Asia - as reported: | 151 | 121 | 92 | 122 | 486 | |||||||||||||||||||||||||||
| China strategic transactions | (31) | (2) | 10 | (38) | (61) | |||||||||||||||||||||||||||
| China footprint actions | (7) | (5) | (2) | — | (14) | |||||||||||||||||||||||||||
| Asia - pro forma | 113 | 114 | 100 | 84 | 411 | |||||||||||||||||||||||||||
| Elimination/corporate: | (19) | (23) | (19) | (17) | (78) | |||||||||||||||||||||||||||
| Total Adient - as reported | 378 | 303 | 118 | 118 | 917 | |||||||||||||||||||||||||||
| Total Adient - pro forma | 325 | 290 | 125 | 70 | 810 | |||||||||||||||||||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Restructuring charges | $ | (13) | $ | (8) | ||||||||||
| Held for sale asset adjustments | 1 | — | ||||||||||||
| $ | (12) | $ | (8) | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Transaction costs | $ | (2) | $ | (2) | ||||||||||
| Brazil indirect tax recoveries | 1 | 28 | ||||||||||||
| Disposal of non-core assets | (1) | — | ||||||||||||
| $ | (2) | $ | 26 | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Restructuring related charges | $ | (1) | $ | — | ||||||||||
| Brazil indirect tax recoveries | 1 | 28 | ||||||||||||
| Purchase accounting amortization | (1) | — | ||||||||||||
| Disposal of non-core assets | (1) | — | ||||||||||||
| $ | (2) | $ | 28 | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Purchase accounting amortization | $ | (13) | $ | (10) | ||||||||||
| Transaction costs | (2) | (2) | ||||||||||||
| $ | (15) | $ | (12) | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Purchase accounting amortization | — | 1 | ||||||||||||
| $ | — | $ | 1 | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Derivative loss on Yanfeng transaction | $ | — | $ | (24) | ||||||||||
| Premium paid on repurchase of debt | — | (4) | ||||||||||||
| Write off of deferred financing costs upon repurchase of debt | — | (10) | ||||||||||||
| Foreign exchange loss on intercompany loan in Russia | (2) | — | ||||||||||||
| $ | (2) | $ | (38) | |||||||||||
| Three Months Ended June 30, | ||||||||||||||
| (in millions) | 2022 | 2021 | ||||||||||||
| Benefits associated with restructuring and impairment charges | $ | — | $ | (2) | ||||||||||
| Brazil indirect tax recoveries | — | 9 | ||||||||||||
Withholding tax adjustments | — | (11) | ||||||||||||
| Valuation allowances | 12 | — | ||||||||||||
| Other reconciling items | (1) | (3) | ||||||||||||
| $ | 11 | $ | (7) | |||||||||||